Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.

Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.

Biochem Pharmacol. 1993 May 25;45(10):2037-43. Unique Identifier : AIDSLINE MED/93290693
Branda RF; Moore AL; Mathews L; McCormack JJ; Zon G; Department of Medicine, University of Vermont, Burlington 05405.

Abstract: Mice developed massive splenomegaly and polyclonal hypergammaglobulinemia within 2 days after intravenous injection of a phosphorothioate oligomer that is antisense to a portion of the rev region of the HIV-1 genome. Histologic examination of spleens from injected animals showed marked expansion of a uniform-appearing population of small lymphocytes and many mitoses. Spleen mononuclear cells (SMNCs) from injected animals showed approximately a 10-fold-increased uptake of [3H]thymidine and production of IgM and IgG. Flow cytometry analysis indicated that the responding cells were predominantly B-lymphocytes. The anti-rev oligomer also was mitogenic in vitro and stimulated immunoglobulin production by normal mouse SMNCs and human peripheral blood mononuclear cells. Similar immunologic effects were observed with an anti-rev 21-mer phosphorothioate, truncated at the 3' end, but not with a 20-mer human p53 antisense phosphorothioate or a 28-mer anti-rev phosphodiester. These observations are consistent with the possibility that DNA sequences homologous to the rev gene participate in the regulation of mammalian lymphocyte activation, proliferation and maturation.

Keywords: Animal Antiviral Agents/*PHARMACOLOGY/TOXICITY Base Sequence Cell Division/DRUG EFFECTS Cell Size/DRUG EFFECTS Comparative Study DNA, Viral/ANALYSIS Genes, rev/*GENETICS Human Hypergammaglobulinemia/CHEMICALLY INDUCED HIV-1/*GENETICS Immune System/*DRUG EFFECTS Leukocytes, Mononuclear/CYTOLOGY/DRUG EFFECTS/IMMUNOLOGY Lymphocyte Transformation/DRUG EFFECTS Mice Mice, Inbred C57BL Molecular Sequence Data Oligonucleotides, Antisense/*PHARMACOLOGY/TOXICITY Species Specificity Spleen/CYTOLOGY/DRUG EFFECTS/EMBRYOLOGY Splenomegaly/CHEMICALLY INDUCED Stimulation, Chemical Support, U.S. Gov't, P.H.S. Thionucleotides/*PHARMACOLOGY/TOXICITY JOURNAL ARTICLE
930930
M9390589

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .